Biomotion Technologies
Biomotion Technologies is pioneering intelligent bioprinting to bridge the gap between research and industrial adoption. Reproducibility remains a major barrier in biofabrication, limiting scalability and clinical applications. Our biofabrication system integrates real-time quality monitoring and leverages advanced process intelligence to ensure batch-to-batch consistency without user intervention. By enabling standardized, data-driven biofabrication, our platform supports the translation of experimental protocols into scalable applications in regenerative medicine, tissue engineering, and biofabricated products.
Work in m2M
Biomotion Technologies is the primary provider of bioprinter technology. We contribute our foundational platform and enhance it to integrate multiple bioprinting techniques. Our systems are being developed to ensure comprehensive process traceability and achieve full GMP compliance, initially targeting clinical applications in cartilage repair. Our innovations enable the reproducible fabrication of cartilage tissue using embedded cells and microtissue building blocks, facilitating their successful clinical translation.
Researchers involved
